Selected Patents
Starpharma holds a central position in the dendrimer IP landscape with a wide portfolio of patents and patent applications covering both the composition and application of dendrimers in pharmaceutical and life-science fields.
Starpharma has over:
- 35 active patent families
- 70 issued patents
- 100 pending applications
For more information on IP, please refer to Starpharma's current Annual Report.
|
